Virtual Medical Academy - All Classes

Classes

Learn with Us

All Classes

Can You Reach EASI Targets Faster? – AD Case with Prof. Naiem Issa Video
Can You Reach EASI Targets Faster? – AD Case with Prof. Naiem Issa
By Virtual Medical Academy
Not Relted Topics
Read More
Deep Response to IL‑13 and IL‑4/13 Inhibition in AD Video
Deep Response to IL‑13 and IL‑4/13 Inhibition in AD
By Organizer , Virtual Medical Academy
Not Relted Topics
Read More
Role of IL‑13 in Atopic Dermatitis (AD) Video
Role of IL‑13 in Atopic Dermatitis (AD)
By Virtual Medical Academy
Not Relted Topics
Read More
Is FACE/Neck AD Treatable? A Real Patient Case with Dr. Fares Alkhayal Video
Is FACE/Neck AD Treatable? A Real Patient Case with Dr. Fares Alkhayal
By Virtual Medical Academy
Not Relted Topics
Read More
Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin Video
Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin
By Virtual Medical Academy
Not Relted Topics
Read More
Second generation basal insulin in advancing T2D therapy Video
Second generation basal insulin in advancing T2D therapy
By Virtual Medical Academy
Not Relted Topics
Read More
Alirocumab: Focus on high CV risk patients and mortality outcomes in Odyssey Video
Alirocumab: Focus on high CV risk patients and mortality outcomes in Odyssey
By Virtual Medical Academy
Not Relted Topics
Read More
Soliqua and Unmet Needs Webinar Summary - William Polonsky and Kathrine Video
Soliqua and Unmet Needs Webinar Summary - William Polonsky and Kathrine
By Virtual Medical Academy
Not Relted Topics
Read More
Timely insulin initiation to limit disease progression Video
Timely insulin initiation to limit disease progression
By Virtual Medical Academy
5.0
Not Relted Topics
Read More
Staying on track: Optimizing the lipid-lowering pathway whilst avoiding treatment gaps Video
Staying on track: Optimizing the lipid-lowering pathway whilst avoiding treatment gaps
By Virtual Medical Academy
Not Relted Topics
Read More
How to prevent the Event in People with T2D and ASCVD Video
How to prevent the Event in People with T2D and ASCVD
By Virtual Medical Academy
Not Relted Topics
Read More
EULAR 2025: How do risk factors impact progression to Psoriatic Arthritis? Video
EULAR 2025: How do risk factors impact progression to Psoriatic Arthritis?
By Virtual Medical Academy
Not Relted Topics
Read More
EULAR 2025 Symposium Highlights Video
EULAR 2025 Symposium Highlights
By Virtual Medical Academy
Not Relted Topics
Read More
Communication with patients with Alzheimer`s Disease 3 Video
Communication with patients with Alzheimer`s Disease 3
By Virtual Medical Academy
Not Relted Topics
Read More
Communication with patients with Alzheimer`s Disease 6 Video
Communication with patients with Alzheimer`s Disease 6
By Virtual Medical Academy
Not Relted Topics
Read More
Communication with patients with Alzheimer`s Disease 5 Video
Communication with patients with Alzheimer`s Disease 5
By Virtual Medical Academy
Not Relted Topics
Read More
Communication with patients with Alzheimer`s Disease 4 Video
Communication with patients with Alzheimer`s Disease 4
By Virtual Medical Academy
Not Relted Topics
Read More
Communication with patients with Alzheimer`s Disease 2 Video
Communication with patients with Alzheimer`s Disease 2
By Virtual Medical Academy
Not Relted Topics
Read More
Communication with patients with Alzheimer`s Disease 1 Video
Communication with patients with Alzheimer`s Disease 1
By Virtual Medical Academy
Not Relted Topics
Read More
Ebglyss Monthly Maintenance Dosing.Simply No lab monitoring , No boxed warning & No dose adjustment Video
Ebglyss Monthly Maintenance Dosing.Simply No lab monitoring , No boxed warning & No dose adjustment
By Virtual Medical Academy
Not Relted Topics
Read More
Discover the 2 Years effcacy data of Ebglyss in Atopic Dermatitis – ADjoin Trial Highlights Video
Discover the 2 Years effcacy data of Ebglyss in Atopic Dermatitis – ADjoin Trial Highlights
By Virtual Medical Academy
Not Relted Topics
Read More
Ebglyss Clinical Trials: Proven Efficacy in Atopic Dermatitis – Advocate 1 and 2 Insights Video
Ebglyss Clinical Trials: Proven Efficacy in Atopic Dermatitis – Advocate 1 and 2 Insights
By Virtual Medical Academy
Not Relted Topics
Read More
Ebglyss features a unique mechanism of action—binding to interleukin-13 with high affinity and a slow dissociation rate Video
Ebglyss features a unique mechanism of action—binding to interleukin-13 with high affinity and a slow dissociation rate
By Virtual Medical Academy
Not Relted Topics
Read More
Unmet Medical Needs in Atopic Dermatitis: Ebglyss – A New IL-13 inhibitor Biologic for Moderate to Severe AD Video
Unmet Medical Needs in Atopic Dermatitis: Ebglyss – A New IL-13 inhibitor Biologic for Moderate to Severe AD
By Virtual Medical Academy
Not Relted Topics
Read More